Compare Stocks

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CARA Cara Therapeutics	$0.69 -5.5%	$0.81	$0.50 ▼ $4.67	$37.72M	0.7	667,695 shs	363,035 shs
GNK Genco Shipping & Trading	$20.29 +0.1%	$19.83	$12.39 ▼ $21.24	$866.99M	1.18	733,000 shs	403,607 shs

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CARA Cara Therapeutics	+3.23%	-9.86%	-19.34%	+34.59%	-82.82%
GNK Genco Shipping & Trading	-0.59%	-1.70%	0.00%	+19.32%	+21.61%

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CARA Cara Therapeutics	3.9152 of 5 stars	3.4	2.0	0.0	4.2	2.0	1.7	1.3
GNK Genco Shipping & Trading	2.3806 of 5 stars	1.3	5.0	2.5	0.0	1.0	1.7	2.5

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CARA Cara Therapeutics	2.75	Moderate Buy	$9.75	1,313.04% Upside
GNK Genco Shipping & Trading	2.67	Moderate Buy	$20.67	1.86% Upside

Current Analyst Ratings

Latest WTB, HFG, GNK, SSPG, and CARA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/10/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
3/28/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
3/6/2024	CARA Cara Therapeutics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$11.00 ➝ $10.00
3/5/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
1/22/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$6.00 ➝ $5.00

(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CARA Cara Therapeutics	$20.97M	1.80	N/A	N/A	$1.05 per share	0.66
GNK Genco Shipping & Trading	$383.83M	2.26	$2.40 per share	8.45	$21.50 per share	0.94

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CARA Cara Therapeutics	-$118.51M	-$2.18	N/A	N/A	N/A	-565.21%	-122.10%	-89.64%	5/20/2024 (Estimated)
GNK Genco Shipping & Trading	-$12.87M	-$0.31	N/A	8.53	N/A	-3.35%	3.10%	2.56%	5/8/2024 (Confirmed)

Latest WTB, HFG, GNK, SSPG, and CARA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2024	N/A	GNK Genco Shipping & Trading	$0.43	N/A	-$0.43	N/A	N/A	N/A
3/4/2024	12/31/2023	CARA Cara Therapeutics	-$0.57	-$0.59	-$0.02	-$0.59	$2.34 million	$3.00 million
2/21/2024	Q4 2023	GNK Genco Shipping & Trading	$0.37	$0.43	+$0.06	$0.75	$72.54 million	$115.50 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CARA Cara Therapeutics	N/A	N/A	N/A	N/A	N/A
GNK Genco Shipping & Trading	$1.64	8.08%	+59.30%	N/A	1 Years

Latest WTB, HFG, GNK, SSPG, and CARA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/21/2024	GNK Genco Shipping & Trading	Quarterly	$0.41	8.41%	3/5/2024	3/6/2024	3/13/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CARA Cara Therapeutics	N/A	4.54	4.43
GNK Genco Shipping & Trading	0.21	4.46	3.70

Ownership

Institutional Ownership

Company	Institutional Ownership
CARA Cara Therapeutics	44.66%
GNK Genco Shipping & Trading	58.62%

Insider Ownership

Company	Insider Ownership
CARA Cara Therapeutics	4.20%
GNK Genco Shipping & Trading	2.50%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CARA Cara Therapeutics	55	54.66 million	52.36 million	Optionable
GNK Genco Shipping & Trading	1,105	42.73 million	41.66 million	Not Optionable

WTB, HFG, GNK, SSPG, and CARA Headlines

Source	Headline
	Genco Shipping & Trading (NYSE:GNK) Stock Rating Lowered by StockNews.com americanbankingnews.com - April 18 at 2:30 AM
	Genco Shipping files definitive proxy; urges holders to reject Economou's nominee seekingalpha.com - April 17 at 7:43 AM
	Genco Shipping & Trading Limited Announces First Quarter 2024 Conference Call and Webcast globenewswire.com - April 10 at 4:15 PM
	Genco Shipping & Trading (NYSE:GNK) Trading Up 2% marketbeat.com - April 10 at 2:51 PM
	George Economou turns up heat on Genco Shipping and its chairman tradewindsnews.com - April 8 at 1:47 PM
	Genco Shipping & Trading Limited (NYSE:GNK) to Post Q2 2024 Earnings of $0.39 Per Share, B. Riley Forecasts americanbankingnews.com - April 8 at 1:36 AM
	How was Genco Shipping’s John Wobensmith rewarded in a leaner year for dry bulk? tradewindsnews.com - April 4 at 2:09 PM
	With 55% ownership of the shares, Genco Shipping & Trading Limited (NYSE:GNK) is heavily dominated by institutional owners finance.yahoo.com - April 4 at 8:56 AM
	Genco Shipping & Trading Limited Files Preliminary Proxy Statement globenewswire.com - April 3 at 5:03 PM
	Genco Shipping: 24% Discount To PNAV, LTV Below 20%, And Attractive Dividends seekingalpha.com - April 3 at 3:45 AM
	SG Americas Securities LLC Purchases 68,310 Shares of Genco Shipping & Trading Limited (NYSE:GNK) marketbeat.com - March 30 at 4:25 AM
	The Crucial Role of Shipping Container Manufacturers in Controlling Inflation msn.com - March 29 at 2:58 PM
	Genco Shipping & Trading Limited (NYSE:GNK) Stock Holdings Lessened by Wellington Management Group LLP marketbeat.com - March 26 at 4:16 AM
	Genco Shipping & Trading Limited (NYSE:GNK) Position Lifted by American Century Companies Inc. marketbeat.com - March 25 at 4:08 AM
	Genco Shipping & Trading (NYSE:GNK) Cut to "Sell" at StockNews.com marketbeat.com - March 22 at 11:10 PM
	Genco Shipping & Trading (NYSE:GNK) Shares Down 3% marketbeat.com - March 20 at 1:51 PM
	Return Trends At Genco Shipping & Trading (NYSE:GNK) Aren't Appealing finance.yahoo.com - March 14 at 7:10 PM
	Genco Shipping Rejects Economou's Nominees; Appoints Das To Board markets.businessinsider.com - March 5 at 1:25 PM
	Genco Shipping & Trading Rejects George Economou Nominees globenewswire.com - March 5 at 9:21 AM
	Genco Shipping & Trading Appoints Paramita Das to Board of Directors globenewswire.com - March 5 at 9:20 AM
	Genco Shipping & Trading Limited Announces Participation at Upcoming Investor Conferences globenewswire.com - March 4 at 4:15 PM
	Genco Shipping & Trading (GNK) Price Target Increased by 5.25% to 22.58 msn.com - February 24 at 2:58 PM
	Insider Sell: Chief Commercial Officer Jesper Christensen Sells 12,404 Shares of Genco Shipping ... finance.yahoo.com - February 24 at 9:58 AM
	Genco Shipping & Trading Ltd. wsj.com - February 24 at 12:01 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cara Therapeutics

NASDAQ:CARA

Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.

Genco Shipping & Trading

NYSE:GNK

Genco Shipping & Trading Limited, together with its subsidiaries, engages in the ocean transportation of drybulk cargoes worldwide. The company owns and operates dry bulk vessels to transports iron ore, grains, coal, steel products, and other drybulk cargoes. It charters its vessels primarily to trading houses, including commodities traders; producers; and government-owned entities. The company was incorporated in 2004 and is headquartered in New York, New York.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial